News

Filter

1 to 9 of 29 results

Toricel gets CHMP nod as first-line RCC drug

01-10-2007

The European Medicines Agency's (EMEA) Committee for Medicinal Products for Human Use (CHMP) has issued…

Gemtuzumab Ozogamicin for InjectionMylotargTemsirolimus InjectionToriselWyeth

Wyeth increases stake in Wyeth KK

17-04-2006

USA-based Wyeth says it has purchased an additional 10% stake in Wyeth KK, the joint venture it co-owns…

EnbreletanerceptGemtuzumab Ozogamicin for InjectionMylotargWyeth

Japanese OK for Wyeth's Mylotarg

08-08-2005

Wyeth Japan says that it has obtained approval for Mylotarg, a proprietary preparation of gemtuzumab…

Gemtuzumab Ozogamicin for InjectionMylotargWyeth

Zeltia's Yondelis enters Phase III

11-04-2005

The value of the Spanish Zeltia group rose 1.3% on the Madrid stock exchange after announcing that its…

Amino AcidsDoxilDoxorubicin Hcl Liposome InjectionEnbreletanerceptGemtuzumab Ozogamicin for InjectionInjectionJohnson & JohnsonMylotargPhysostigmine SalicylateWyeth

Wyeth oncology researchers honored

30-08-2004

Wyeth Pharmaceuticals says that five oncology researchers who led thecompany's development of the first…

Gemtuzumab Ozogamicin for InjectionMylotargWyeth

PDL's 1st-qtr plunges into loss but revenues up 21%

10-05-2004

Protein Design Labs has recorded a net loss of $12.6 million, or $0.13 per share, for the first quarter…

daclizumabEfalizumabGemtuzumab Ozogamicin for InjectionGenentechHerceptinMylotargOmalizumabPalivizumabRaptivaRocheSynagistrastuzumabWyethXolairZenapax

Wyeth to boost sales 60% in Japan with new drug launches

22-09-2003

US drug major Wyeth has said it aims to boost sales in Japan 60% to 100 billion yen ($858.1 million)...

EnbreletanerceptGemtuzumab Ozogamicin for InjectionMylotargWyeth

1 to 9 of 29 results

COMPANY SPOTLIGHT

Menarini

Back to top